a public good project by the
Synthesis
Company
of California

© 2026

Dale L. Barnard | doi.page

0 works0 citations0 h-index

Dale L. Barnard

Publications by Year

Research Areas

Respiratory viral infections research, Influenza Virus Research Studies, SARS-CoV-2 and COVID-19 Research, Virus-based gene therapy research, Viral gastroenteritis research and epidemiology

Most-Cited Works

→ Favipiravir (T-705), a novel viral RNA polymerase inhibitor(2013)1,058 cited
→ Protease inhibitors targeting coronavirus and filovirus entry(2015)619 cited
→ T-705 (favipiravir) and related compounds: Novel broad-spectrum inhibitors of RNA viral infections(2009)468 cited
→ Broad-SpectrumIn VitroActivity andIn VivoEfficacy of the Antiviral Protein Griffithsin against Emerging Viruses of the FamilyCoronaviridae(2009)303 cited
→ Severe Acute Respiratory Syndrome-Associated Coronavirus Vaccines Formulated with Delta Inulin Adjuvants Provide Enhanced Protection while Ameliorating Lung Eosinophilic Immunopathology(2014)223 cited
→ Evaluation of Immunomodulators, Interferons and Known in Vitro SARS-CoV Inhibitors for Inhibition of SARS-Cov Replication in BALB/c Mice(2006)210 cited

→ Animal models for the study of influenza pathogenesis and therapy(2009)175 cited

→ Evaluation of the antiviral activity of anthraquinones, anthrones and anthraquinone derivatives against human cytomegalovirus(1992)170 cited

→ Inhibition of Severe Acute Respiratory Syndrome-Associated Coronavirus (SARSCoV) by Calpain Inhibitors and β-D-N4-Hydroxycytidine(2004)150 cited

→ A new mouse-adapted strain of SARS-CoV as a lethal model for evaluating antiviral agents in vitro and in vivo(2009)146 cited